List of Figures
Figure 1: Asthma Therapeutics Market, Comparative Efficacy and Safety Heatmap for Marketed Products 38
Figure 2: Asthma Therapeutics Market, Global, Pipeline, 2016 41
Figure 3: Asthma Therapeutics Market, Global, Pipeline by Molecular Target, 2016 44
Figure 4: Asthma Therapeutics Market, Global, Pipeline by Molecular Target and Stage of Development, 2016 45
Figure 5: Asthma Therapeutics Market, Asia-Pacific, Reslizumab Forecast ($m), 2017–2023 47
Figure 6: Asthma Therapeutics Market, Asia-Pacific, Dupilumab Forecast ($m), 2019–2023 49
Figure 7: Asthma Therapeutics Market, Asia-Pacific, Tralokinumab Forecast ($m), 2019–2023 51
Figure 8: Asthma Therapeutics Market, Asia-Pacific, Benralizumab Forecast ($m), 2018–2023 53
Figure 9: Asthma Therapeutics Market, Asia-Pacific, Fevipiprant Forecast ($m), 2021–2023 54
Figure 10: Asthma Therapeutics Market, Comparative Efficacy and Safety Heatmap for Pipeline Products 55
Figure 11: Asthma Therapeutics Market, Competitor Matrix for Asthma Marketed and Pipeline Products, 2016 57
Figure 12: Asthma Therapeutics, Global, Average Clinical Trial Failure Rate (%), 2006–2016 59
Figure 13: Asthma Therapeutics, Global, Clinical Trial Failure Rate by Molecule Type, 2006–2016 60
Figure 14: Asthma Therapeutics, Global, Clinical Trial Failure Rate by Molecular Target, 2006–2016 61
Figure 15: Asthma Therapeutics, Global, Clinical Trial Duration by Phase and Molecule Type, 2006–2016 62
Figure 16: Asthma Therapeutics, Global, Clinical Trial Duration by Phase and Molecular Target, 2006–2016 63
Figure 17: Asthma Therapeutics, Global, Clinical Trial Size per Individual Trial by Stage of Development and Molecule Type, 2006–2016 64
Figure 18: Asthma Therapeutics, Global, Clinical Trial Size per Individual Trial by Stage of Development and Molecular Target, 2006–2016 65
Figure 19: Asthma Therapeutics, Global, Clinical Trial Size per Product by Stage of Development and Molecule Type, 2006–2016 66
Figure 20: Asthma Therapeutics, Global, Clinical Trial Size per Product by Stage of Development and Molecular Target, 2006–2016 67
Figure 21: Asthma Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecule Type 68
Figure 22: Asthma Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecular Target 68
Figure 23: Asthma Therapeutics Market, Asia-Pacific, Treatment Patterns, 2016–2023 70
Figure 24: Asthma Therapeutics Market, Asia-Pacific, Market Size ($bn), 2016–2023 71
Figure 25: Asthma Therapeutics Market, India, Treatment Usage Patterns (million), 2016–2023 72
Figure 26: Asthma Therapeutics Market, India, Annual Cost of Therapy ($), 2016–2023 73
Figure 27: Asthma Therapeutics Market, India, Market Size ($m), 2016–2023 74
Figure 28: Asthma Therapeutics Market, China, Treatment Usage Patterns, 2016–2023 75
Figure 29: Asthma Therapeutics Market, China, Annual Cost of Therapy ($), 2016–2023 76
Figure 30: Asthma Therapeutics Market, China, Market Size ($m), 2016–2023 77
Figure 31: Asthma Therapeutics Market, Australia, Treatment Usage Patterns (million), 2016–2023 78
Figure 32: Asthma Therapeutics Market, Australia, Annual Cost of Therapy ($), 2016–2023 79
Figure 33: Asthma Therapeutics Market, Australia, Market Size ($m), 2016–2023 80
Figure 34: Asthma Therapeutics Market, South Korea, Treatment Usage Patterns (million), 2016–2023 81
Figure 35: Asthma Therapeutics Market, South Korea, Annual Cost of Therapy ($), 2016–2023 82
Figure 36: Asthma Therapeutics Market, South Korea, Market Size ($m), 2016–2023 83
Figure 37: Asthma Therapeutics Market, Japan, Treatment Usage Patterns (million), 2016–2023 84
Figure 38: Asthma Therapeutics Market, Japan, Annual Cost of Therapy ($), 2016–2023 85
Figure 39: Asthma Therapeutics Market, Japan, Market Size ($m), 2016–2023 86
Figure 40: Asthma Therapeutics Market, Global, Licensing Deals by Region and Value, 2006–2016 91
Figure 41: Asthma Therapeutics Market, Global, Number of Disclosed and Undisclosed Licensing Deals by Year, Aggregate Deal Value ($m) and Aggregate Upfront Value ($m), 2006–2016 92
Figure 42: Asthma Therapeutics Market, Global, Licensing Deals by Stage of Development, Deal Value ($m) and Upfront Payment Value ($m), 2006–2016 93
Figure 43: Asthma Therapeutics Market, Global, Licensing Deals by Molecule Type, Stage of Development and Aggregate Deal Value ($m), 2006–2016 94
Figure 44: Asthma Therapeutics Market, Global, Licensing Deals by Molecular Target, Aggregate Deal Value ($m) and Aggregate Upfront Payment Value ($m), 2006–2016 95
Figure 45: Asthma Therapeutics Market, Global, Co-development Deals by Region, 2006–2016 99
Figure 46: Asthma Therapeutics Market, Global, Number of Disclosed and Undisclosed Co-development Deals by Year, Aggregate Deal Value ($m) and Aggregate Upfront Value ($m), 2006–2016 100
Figure 47: Asthma Therapeutics Market, Global, Co-development Deals by Stage of Development, Deal Value ($m) and Upfront Payment Value ($m), 2006–2016 101
Figure 48: Asthma Therapeutics Market, Global, Co-development Deals by Molecule Type, Stage of Development and Aggregate Deal Value ($m), 2006–2016 102
Figure 49: Asthma Therapeutics Market, Global, Co-development Deals by Molecular Target, Aggregate Deal Value ($m) and Aggregate Upfront Payment Value ($m), 2006–2016 103